Skip to main content
Premium Trial:

Request an Annual Quote

GeneTrace Introduces High-Throughput SNP Validator

Premium

ALAMEDA, Calif.--GeneTrace Systems, a privately held genomics and bioinformatics company, inaugurated its automated high-throughput single-nucleotide polymorphism (SNP) validation process line last month. Capable of generating SNP data on 10,000 samples per day, it is expected to operate at a rate of 50,000 per day by July.

GeneTrace said it is combining its expertise in marker design, automation, and time-of-flight mass spectrometry to construct tools to study SNPs. George LaMotte, CEO of GeneTrace Systems, said, "The analysis of these new datasets with our bioinformatics tools and integration with our existing database will provide another level of information and value to our partners."

The company's core technology platforms include geno-typing through the characterization of SNPs and microsatellites; high-throughput gene expression screening of chemical treated cells; analysis of gene expression patterns for target discovery; and systems for proteomics analysis. GeneTrace is working with Monsanto to design agricultural applications of its technology focused on genotyping various plants and animals.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.